FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TEGEDER, I.
Right arrow Articles by GEISSLINGER, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TEGEDER, I.
Right arrow Articles by GEISSLINGER, G.
(The FASEB Journal. 2001;15:2057-2072.)
© 2001 FASEB

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

IRMGARD TEGEDER, JOSEF PFEILSCHIFTER and GERD GEISSLINGER1

Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, 60590 Frankfurt am Main, Germany

1Correspondence: Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany. E-mail: geisslinger{at}em.uni-frankfurt.de

Several studies have demonstrated unequivocally that certain nonsteroidal anti-inflammatory drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti-inflammatory and antiproliferative effects independent of cyclooxygenase activity and prostaglandin synthesis inhibition. These effects are mediated through inhibition of certain transcription factors such as NF-{kappa}B and AP-1. The respective NSAIDs might interfere directly with the transcription factors, but their effects are probably mediated predominantly through alterations of the activity of cellular kinases such as IKKß, Erk, p38 MAPK, or Cdks. These effects apparently are not shared by all NSAIDs, since indomethacin failed to inhibit NF-{kappa}B and AP-1 activation as well as Erk and Cdk activity. In contrast, indomethacin was able to activate PPAR{gamma}, which was not affected by sodium salicylate or aspirin. The differences in cyclooxygenase-independent mechanisms may have consequences for the specific use of these drugs in individual patients because additional effects may either enhance the efficacy or reduce the toxicity of the respective compounds.—Tegeder, I., Pfeilschifter, J., Geisslinger, G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors


Key Words: aspirin • NSAIDs • apoptosis • metalloproteinase




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. John-Aryankalayil, S. T. Palayoor, D. Cerna, M. T. Falduto, S. R. Magnuson, and C. N. Coleman
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells
Mol. Cancer Ther., January 1, 2009; 8(1): 261 - 273.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
K. A. Blackwell, C. C. Pilbeam, and L. G. Raisz
Take Two Aspirin: for Osteoporosis?
IBMS BoneKEy, November 1, 2008; 5(11): 436 - 440.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Okamura, Y. Takano, N. Hiramatsu, K. Hayakawa, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura
Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1495 - F1503.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
F. Di Renzo, G. Cappelletti, M. L. Broccia, E. Giavini, and E. Menegola
The Inhibition of Embryonic Histone Deacetylases as the Possible Mechanism Accounting for Axial Skeletal Malformations Induced by Sodium Salicylate
Toxicol. Sci., August 1, 2008; 104(2): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. A. Kotilinek, M. A. Westerman, Q. Wang, K. Panizzon, G. P. Lim, A. Simonyi, S. Lesne, A. Falinska, L. H. Younkin, S. G. Younkin, et al.
Cyclooxygenase-2 inhibition improves amyloid-{beta}-mediated suppression of memory and synaptic plasticity
Brain, March 1, 2008; 131(3): 651 - 664.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-K. Seo, H.-O. Jin, H.-C. Lee, S.-H. Woo, E.-S. Kim, D.-H. Yoo, S.-J. Lee, S. An, C.-H. Rhee, S.-I. Hong, et al.
Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells
Mol. Pharmacol., March 1, 2008; 73(3): 1005 - 1012.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Kardosh, E. B. Golden, P. Pyrko, J. Uddin, F. M. Hofman, T. C. Chen, S. G. Louie, N. A. Petasis, and A. H. Schonthal
Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib
Cancer Res., February 1, 2008; 68(3): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. E. Hollingshead, M. G. Borland, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters
Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms
Carcinogenesis, January 1, 2008; 29(1): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. J. Quann, F. Khwaja, and D. Djakiew
The p38 MAPK Pathway Mediates Aryl Propionic Acid Induced Messenger RNA Stability of p75NTR in Prostate Cancer Cells
Cancer Res., December 1, 2007; 67(23): 11402 - 11410.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. L. Mackey, M. Kjaer, S. Dandanell, K. H. Mikkelsen, L. Holm, S. Dossing, F. Kadi, S. O. Koskinen, C. H. Jensen, H. D. Schroder, et al.
The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans
J Appl Physiol, August 1, 2007; 103(2): 425 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. M. Bamman
Take two NSAIDs and call on your satellite cells in the morning
J Appl Physiol, August 1, 2007; 103(2): 415 - 416.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Roman, A. F. de Arriba, S. Barron, P. Michelena, M. Giral, M. Merlos, E. Bailon, M. Comalada, J. Galvez, A. Zarzuelo, et al.
UR-1505, a New Salicylate, Blocks T Cell Activation through Nuclear Factor of Activated T Cells
Mol. Pharmacol., August 1, 2007; 72(2): 269 - 279.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. A. Stark, K. Reid, O. J. Sansom, F. V. Din, S. Guichard, I. Mayer, D. I. Jodrell, A. R. Clarke, and M. G. Dunlop
Aspirin activates the NF-{kappa}B signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer
Carcinogenesis, May 1, 2007; 28(5): 968 - 976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. S. Akarsu and S. Mamuk
Escherichia coli lipopolysaccharides produce serotype-specific hypothermic response in biotelemetered rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1846 - R1850.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Silva, D. Wang, A. A. Komar, B. A. Castilho, and B. R. G. Williams
Salicylates Trigger Protein Synthesis Inhibition in a Protein Kinase R-like Endoplasmic Reticulum Kinase-dependent Manner
J. Biol. Chem., April 6, 2007; 282(14): 10164 - 10171.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Pyrko, A. Kardosh, Y.-T. Liu, N. Soriano, W. Xiong, R. H. Chow, J. Uddin, N. A. Petasis, A. K. Mircheff, R. A. Farley, et al.
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib
Mol. Cancer Ther., April 1, 2007; 6(4): 1262 - 1275.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Zheng, S. J. Howell, D. A. Hatala, K. Huang, and T. S. Kern
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Diabetes, February 1, 2007; 56(2): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
U. Vogel, J. Christensen, B. A Nexo, H. Wallin, S. Friis, and A. Tjonneland
Peroxisome profilerator-activated receptor{gamma}2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes
Carcinogenesis, February 1, 2007; 28(2): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Wohlschlaeger, K. J. Schmitz, J. Palatty, A. Takeda, N. Takeda, C. Vahlhaus, B. Levkau, J. Stypmann, C. Schmid, K. W. Schmid, et al.
Roles of cyclooxygenase-2 and phosphorylated Akt ( T hr308) in cardiac hypertrophy regression mediated by left-ventricular unloading
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-H. Kim, C.-I. Hwang, Y.-S. Juhnn, J.-H. Lee, W.-Y. Park, and Y.-S. Song
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells
Carcinogenesis, January 1, 2007; 28(1): 223 - 231.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Mittal, S.-Y. Peak-Chew, and H. T. McMahon
Acetylation of MEK2 and I{kappa}B kinase (IKK) activation loop residues by YopJ inhibits signaling
PNAS, December 5, 2006; 103(49): 18574 - 18579.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Negrotto, E. Malaver, M. E. Alvarez, N. Pacienza, L. P. D'Atri, R. G. Pozner, R. M. Gomez, and M. Schattner
Aspirin and Salicylate Suppress Polymorphonuclear Apoptosis Delay Mediated by Proinflammatory Stimuli
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 972 - 979.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. Cianchi, C. Cortesini, L. Magnelli, E. Fanti, L. Papucci, N. Schiavone, L. Messerini, A. Vannacci, S. Capaccioli, F. Perna, et al.
Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Mol. Cancer Ther., November 1, 2006; 5(11): 2716 - 2726.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M Gaytan, C Bellido, C Morales, J E Sanchez-Criado, and F Gaytan
Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat.
Reproduction, October 1, 2006; 132(4): 571 - 577.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. M. Borthwick, A. S. Johnson, M. Partington, J. Burn, R. Wilson, and H. M. Arthur
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
FASEB J, October 1, 2006; 20(12): 2009 - 2016.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-H. Kim, C.-I. Hwang, W.-Y. Park, J.-H. Lee, and Y.-S. Song
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells
Carcinogenesis, October 1, 2006; 27(10): 1961 - 1969.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Gravel and M. M. Vijayan
Salicylate Disrupts Interrenal Steroidogenesis and Brain Glucocorticoid Receptor Expression in Rainbow Trout
Toxicol. Sci., September 1, 2006; 93(1): 41 - 49.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. K. Glebov, L. M. Rodriguez, P. Lynch, S. Patterson, H. Lynch, K. Nakahara, J. Jenkins, J. Cliatt, C.-J. Humbyrd, J. DeNobile, et al.
Celecoxib treatment alters the gene expression profile of normal colonic mucosa.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1382 - 1391.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. Tancevski, A. Wehinger, W. Schgoer, P. Eller, S. Cuzzocrea, B. Foeger, J. R. Patsch, and A. Ritsch
Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice
FASEB J, July 1, 2006; 20(9): 1328 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Furst, S. B. Blumenthal, A. K. Kiemer, S. Zahler, and A. M. Vollmar
Nuclear Factor-{kappa}B-Independent Anti-Inflammatory Action of Salicylate in Human Endothelial Cells: Induction of Heme Oxygenase-1 by the c-Jun N-Terminal Kinase/Activator Protein-1 Pathway
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 389 - 394.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. Grosch, T. J. Maier, S. Schiffmann, and G. Geisslinger
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.
J Natl Cancer Inst, June 7, 2006; 98(11): 736 - 747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. A. Bondesen, S. T. Mills, and G. K. Pavlath
The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1651 - C1659.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Alloza, A. Baxter, Q. Chen, R. Matthiesen, and K. Vandenbroeck
Celecoxib Inhibits Interleukin-12 {alpha}beta and beta2 Folding and Secretion by a Novel COX2-Independent Mechanism Involving Chaperones of the Endoplasmic Reticulum
Mol. Pharmacol., May 1, 2006; 69(5): 1579 - 1587.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
Q. Li, F. Jimenez-Krassel, Y. Kobayashi, J. J Ireland, and G. W Smith
Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
Reproduction, March 1, 2006; 131(3): 533 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Derouet, L. Thomas, D. A. Moulding, C. Akgul, A. Cross, R. J. Moots, and S. W. Edwards
Sodium Salicylate Promotes Neutrophil Apoptosis by Stimulating Caspase-Dependent Turnover of Mcl-1
J. Immunol., January 15, 2006; 176(2): 957 - 965.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Kardosh, N. Soriano, Y.-T. Liu, J. Uddin, N. A. Petasis, F. M. Hofman, T. C. Chen, and A. H. Schonthal
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib
Blood, December 15, 2005; 106(13): 4330 - 4338.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Diabetes, December 1, 2005; 54(12): 3418 - 3426.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. Liang, Q. Wang, T. Hand, L. Wu, R. M. Breyer, T. J. Montine, and K. Andreasson
Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease
J. Neurosci., November 2, 2005; 25(44): 10180 - 10187.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. M. Backhus, N. A. Petasis, J. Uddin, A. H. Schonthal, R. D. Bart, Y. Lin, V. A. Starnes, and R. M. Bremner
Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1406 - 1412.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. G. Bottone Jr., Y. Moon, B. Alston-Mills, and T. E. Eling
Transcriptional Regulation of Activating Transcription Factor 3 Involves the Early Growth Response-1 Gene
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 668 - 677.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Moon, F. G. Bottone Jr., M. F. McEntee, and T. E. Eling
Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1
Mol. Cancer Ther., October 1, 2005; 4(10): 1551 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. T. Palayoor, M. J. Arayankalayil, A. Shoaibi, and C. N. Coleman
Radiation Sensitivity of Human Carcinoma Cells Transfected with Small Interfering RNA Targeted against Cyclooxygenase-2
Clin. Cancer Res., October 1, 2005; 11(19): 6980 - 6986.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Koenigsknecht-Talboo and G. E. Landreth
Microglial Phagocytosis Induced by Fibrillar {beta}-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines
J. Neurosci., September 7, 2005; 25(36): 8240 - 8249.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. M. Kavvada, J. G. Murray, V. A. Moore, A. G. A. Coombes, and P. J. Hanson
A Collagen IV Matrix Is Required for Guinea Pig Gastric Epithelial Cell Monolayers to Provide an Optimal Model of the Stomach Surface for Biopharmaceutical Screening
J Biomol Screen, August 1, 2005; 10(5): 495 - 507.
[Abstract] [PDF]


Home page
J. Immunol.Home page
S. Sharma, L. Zhu, S. C. Yang, L. Zhang, J. Lin, S. Hillinger, B. Gardner, K. Reckamp, R. M. Strieter, M. Huang, et al.
Cyclooxygenase 2 Inhibition Promotes IFN-{gamma}-Dependent Enhancement of Antitumor Responses
J. Immunol., July 15, 2005; 175(2): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Yasui, T. Hideshima, M. Hamasaki, A. M. Roccaro, N. Shiraishi, S. Kumar, P. Tassone, K. Ishitsuka, N. Raje, Y.-T. Tai, et al.
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma
Blood, July 15, 2005; 106(2): 706 - 712.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. D. Dwyer-Nield, M. C. Srebernak, B. S. Barrett, J. Ahn, P. Cosper, A. M. Meyer, L. R. Kisley, A. K. Bauer, D. C. Thompson, and A. M. Malkinson
Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines
Carcinogenesis, July 1, 2005; 26(7): 1196 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A Vignaud, J Cebrian, I Martelly, J.-P Caruelle, and A Ferry
Effect of anti-inflammatory and antioxidant drugs on the long-term repair of severely injured mouse skeletal muscle
Exp Physiol, July 1, 2005; 90(4): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, C. Kuiperi, K. O'Banion, T. Klockgether, F. Van Leuven, and G. E. Landreth
Acute treatment with the PPAR{gamma} agonist pioglitazone and ibuprofen reduces glial inflammation and A{beta}1-42 levels in APPV717I transgenic mice
Brain, June 1, 2005; 128(6): 1442 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Liao, R. Komaki, L. Milas, C. Yuan, M. Kies, J. Y. Chang, M. Jeter, T. Guerrero, G. Blumenschien, C. M. Smith, et al.
A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non-Small Cell Lung Cancer
Clin. Cancer Res., May 1, 2005; 11(9): 3342 - 3348.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. R. Brown and R. N. DuBois
COX-2: A Molecular Target for Colorectal Cancer Prevention
J. Clin. Oncol., April 20, 2005; 23(12): 2840 - 2855.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Katada, H. Saito, and A. Ohashi
Significance of Cyclooxygenase-2 Induced via p38 Mitogen-Activated Protein Kinase in Mechanical Stimulus-Induced Peritoneal Adhesion in Mice
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Oida, B. Gopalan, R. Miyahara, S. Inoue, C. D. Branch, A. M. Mhashilkar, E. Lin, B. N. Bekele, J. A. Roth, S. Chada, et al.
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer
Mol. Cancer Ther., February 1, 2005; 4(2): 291 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
U. Puhlmann, C. Ziemann, G. Ruedell, H. Vorwerk, D. Schaefer, C. Langebrake, P. Schuermann, U. Creutzig, and D. Reinhardt
Impact of the Cyclooxygenase System on Doxorubicin-Induced Functional Multidrug Resistance 1 Overexpression and Doxorubicin Sensitivity in Acute Myeloid Leukemic HL-60 Cells
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 346 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Lanz, G. J. Fici, and K. M. Merchant
Lack of Specific Amyloid-{beta}(1-42) Suppression by Nonsteroidal Anti-Inflammatory Drugs in Young, Plaque-Free Tg2576 Mice and in Guinea Pig Neuronal Cultures
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. R. Bauman, S. I. Rudnick, L. M. Szewczuk, Y. Jin, S. Gopishetty, and T. M. Penning
Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes
Mol. Pharmacol., January 1, 2005; 67(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Aceves, A. Duenas, C. Gomez, E. San Vicente, M. S. Crespo, and C. Garcia-Rodriguez
A New Pharmacological Effect of Salicylates: Inhibition of NFAT-Dependent Transcription
J. Immunol., November 1, 2004; 173(9): 5721 - 5729.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. H. Hennekens, K. Schror, S. Weisman, and G. A. FitzGerald
Terms and Conditions: Semantic Complexity and Aspirin Resistance
Circulation, September 21, 2004; 110(12): 1706 - 1708.
[Full Text] [PDF]


Home page
Cancer Res.Home page
F. Khwaja, J. Allen, J. Lynch, P. Andrews, and D. Djakiew
Ibuprofen Inhibits Survival of Bladder Cancer Cells by Induced Expression of the p75NTR Tumor Suppressor Protein
Cancer Res., September 1, 2004; 64(17): 6207 - 6213.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. E. De Larco, B. R. K. Wuertz, and L. T. Furcht
The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8
Clin. Cancer Res., August 1, 2004; 10(15): 4895 - 4900.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. A. Bondesen, S. T. Mills, K. M. Kegley, and G. K. Pavlath
The COX-2 pathway is essential during early stages of skeletal muscle regeneration
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C475 - C483.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Huycke and H. R. Gaskins
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Aronoff, C. Canetti, and M. Peters-Golden
Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP
J. Immunol., July 1, 2004; 173(1): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. C. H. Hardwick, M. van Santen, G. R. van den Brink, S. J. H. van Deventer, and M. P. Peppelenbosch
DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1
Carcinogenesis, July 1, 2004; 25(7): 1293 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Schonthal, C. R. Herzog, M. V. Swamy, and C. V. Rao
Correspondence re: M. V. Swamy et al., Inhibition of COX-2 in Colon Cancer Cell Lines by Celecoxib Increases the Nuclear Localization of Active p53. Cancer Res 2003;63:5239-42.
Cancer Res., April 15, 2004; 64(8): 2937 - 2938.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Osakabe, A. Yasuda, M. Natsume, and T. Yoshikawa
Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model
Carcinogenesis, April 1, 2004; 25(4): 549 - 557.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
D. Ishiyama, D. Vujaklija, and J. Davies
Novel Pathway of Salicylate Degradation by Streptomyces sp. Strain WA46
Appl. Envir. Microbiol., March 1, 2004; 70(3): 1297 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Lovering, J. P. Ride, C. M. Bunce, J. C. Desmond, S. M. Cummings, and S. A. White
Crystal Structures of Prostaglandin D2 11-Ketoreductase (AKR1C3) in Complex with the Nonsteroidal Anti-Inflammatory Drugs Flufenamic Acid and Indomethacin
Cancer Res., March 1, 2004; 64(5): 1802 - 1810.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, B. Houweling, A. Zarbanoui, and D. J. Duncker
Interaction between prostanoids and nitric oxide in regulation of systemic, pulmonary, and coronary vascular tone in exercising swine
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1114 - H1123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. F. Badawi, M. B. Eldeen, Y. Liu, E. A. Ross, and M. Z. Badr
Inhibition of Rat Mammary Gland Carcinogenesis by Simultaneous Targeting of Cyclooxygenase-2 and Peroxisome Proliferator-activated Receptor {gamma}
Cancer Res., February 1, 2004; 64(3): 1181 - 1189.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Campa, S. Zienolddiny, V. Maggini, V. Skaug, A. Haugen, and F. Canzian
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer
Carcinogenesis, February 1, 2004; 25(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Weggen, J. L. Eriksen, S. A. Sagi, C. U. Pietrzik, V. Ozols, A. Fauq, Todd. E. Golde, and E. H. Koo
Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid {beta}42 Production by Direct Modulation of {gamma}-Secretase Activity
J. Biol. Chem., August 22, 2003; 278(34): 31831 - 31837.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, A. L. Biere, M. Citron, and G. Landreth
Anti-Inflammatory Drug Therapy Alters {beta}-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease
J. Neurosci., August 20, 2003; 23(20): 7504 - 7509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Weggen, J. L. Eriksen, S. A. Sagi, C. U. Pietrzik, Todd. E. Golde, and E. H. Koo
A{beta}42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain
J. Biol. Chem., August 15, 2003; 278(33): 30748 - 30754.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Grosser and H. Schroder
Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. G. Bottone Jr., J. M. Martinez, J. B. Collins, C. A. Afshari, and T. E. Eling
Gene Modulation by the Cyclooxygenase Inhibitor, Sulindac Sulfide, in Human Colorectal Carcinoma Cells: POSSIBLE LINK TO APOPTOSIS
J. Biol. Chem., July 3, 2003; 278(28): 25790 - 25801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. A. Benitah, P. F. Valeron, and J. C. Lacal
ROCK and Nuclear Factor-{kappa}B-dependent Activation of Cyclooxygenase-2 by Rho GTPases: Effects on Tumor Growth and Therapeutic Consequences
Mol. Biol. Cell, July 1, 2003; 14(7): 3041 - 3054.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takahashi, I. Hayashi, Y. Tominari, K. Rikimaru, Y. Morohashi, T. Kan, H. Natsugari, T. Fukuyama, T. Tomita, and T. Iwatsubo
Sulindac Sulfide Is a Noncompetitive gamma -Secretase Inhibitor That Preferentially Reduces Abeta 42 Generation
J. Biol. Chem., May 9, 2003; 278(20): 18664 - 18670.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Hawcroft, S. H. Gardner, and M. A. Hull
Activation of Peroxisome Proliferator-Activated Receptor gamma Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 632 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. G. Wilson, C. D. Bryant, W. R. Lariviere, M. S. Olsen, B. E. Giles, E. J. Chesler, and J. S. Mogil
The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 755 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-B. Yoon, S.-J. Kim, S.-G. Hwang, S. Chang, S.-S. Kang, and J.-S. Chun
Non-steroidal Anti-inflammatory Drugs Inhibit Nitric Oxide-induced Apoptosis and Dedifferentiation of Articular Chondrocytes Independent of Cyclooxygenase Activity
J. Biol. Chem., April 18, 2003; 278(17): 15319 - 15325.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Maccarrone, N. Battista, M. Meloni, M. Bari, G. Galleri, P. Pippia, A. Cogoli, and A. Finazzi-Agro
Creating conditions similar to those that occur during exposure of cells to microgravity induces apoptosis in human lymphocytes by 5-lipoxygenase-mediated mitochondrial uncoupling and cytochrome c release
J. Leukoc. Biol., April 1, 2003; 73(4): 472 - 481.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C Kreiss, L A Birder, S Kiss, M M VanBibber, and A J Bauer
COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus
Gut, April 1, 2003; 52(4): 527 - 534.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Komninou, A. Ayonote, J. P. Richie Jr., and B. Rigas
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Experimental Biology and Medicine, April 1, 2003; 228(4): 396 - 405.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Takano, A. V. Cybulsky, W. A. Cupples, D. O. Ajikobi, J. Papillon, and L. Aoudjit
Inhibition of Cyclooxygenases Reduces Complement-Induced Glomerular Epithelial Cell Injury and Proteinuria in Passive Heymann Nephritis
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 240 - 249.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Zou, B. Attuwaybi, and B. C. Kone
Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G713 - G721.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. A. Callejas, A. Fernandez-Martinez, A. Castrillo, L. Bosca, and P. Martin-Sanz
Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor kappa B and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide
Mol. Pharmacol., March 1, 2003; 63(3): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. M. Aronoff, O. Boutaud, L. J. Marnett, and J. A. Oates
Inhibition of Prostaglandin H2 Synthases by Salicylate Is Dependent on the Oxidative State of the Enzymes
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. C. Desmond, J. C. Mountford, M. T. Drayson, E. A. Walker, M. Hewison, J. P. Ride, Q. T. Luong, R. E. Hayden, E. F. Vanin, and C. M. Bunce
The Aldo-Keto Reductase AKR1C3 Is a Novel Suppressor of Cell Differentiation That Provides a Plausible Target for the Non-Cyclooxygenase-dependent Antineoplastic Actions of Nonsteroidal Anti-Inflammatory Drugs
Cancer Res., January 15, 2003; 63(2): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Blais, J. Zhang, and S. Rivest
In Altering the Release of Glucocorticoids, Ketorolac Exacerbates the Effects of Systemic Immune Stimuli on Expression of Proinflammatory Genes in the Brain
Endocrinology, December 1, 2002; 143(12): 4820 - 4827.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. M. Duffy and R. L. Stouffer
Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys
Hum. Reprod., November 1, 2002; 17(11): 2825 - 2831.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Wick, G. Hurteau, C. Dessev, D. Chan, M. W. Geraci, R. A. Winn, L. E. Heasley, and R. A. Nemenoff
Peroxisome Proliferator-Activated Receptor-gamma Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth
Mol. Pharmacol., November 1, 2002; 62(5): 1207 - 1214.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. R. Kisley, B. S. Barrett, L. D. Dwyer-Nield, A. K. Bauer, D. C. Thompson, and A. M. Malkinson
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice
Carcinogenesis, October 1, 2002; 23(10): 1653 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. E. L. Stubbs, P. Schratl, A. Hartnell, T. J. Williams, B. A. Peskar, A. Heinemann, and I. Sabroe
Indomethacin Causes Prostaglandin D2-like and Eotaxin-like Selective Responses in Eosinophils and Basophils
J. Biol. Chem., July 12, 2002; 277(29): 26012 - 26020.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Yamazaki, N. Kusunoki, T. Matsuzaki, S. Hashimoto, and S. Kawai
Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Association with Activation of Peroxisome Proliferator-Activated Receptor gamma in Rheumatoid Synovial Cells
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 18 - 25.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Sadoshima
Novel AT1 Receptor-Independent Functions of Losartan
Circ. Res., April 19, 2002; 90(7): 754 - 756.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The Federation of American Societies for Experimental Biology.